Dimension Capital raises $800 million third fund for biotech and AI

Dimension Capital has raised an $800 million third fund, expanding its latest vehicle by 60% from the $500 million second fund it announced 18 months earlier. The four-year-old firm, founded in 2022 by Zavain Dar, Adam Goulburn and Nan Li, is based in New York and San Francisco and describes itself as a multistage, research-oriented investor at the frontier of science and compute.

In practical terms, that strategy means backing companies that use artificial intelligence and automation to turn scientific discovery into a compute problem. That can include AI for biology, drug discovery, materials research and lab automation, areas where faster modeling, higher-throughput experiments and better data pipelines can compress the time and cost of finding new drugs or new industrial materials.

The size of the new fund matters because it landed above the level Dimension had previously been seeking. Earlier reporting said the firm was aiming for as much as $750 million for a third life sciences fund, making the final $800 million raise a step beyond those expectations. The larger vehicle also follows a second fund that was framed around the intersection of tech and life sciences, a niche that has remained attractive even as many other parts of the venture market have tightened.

Dimension’s co-founders have consistently pitched the firm as highly focused on companies that sit in both life sciences and technology, rather than on traditional biotech alone. That positioning has helped the firm define a narrower lane inside a crowded market for AI investing, where capital has increasingly gravitated toward sectors with clear links to real-world production, scientific workflows and measurable technical advantages.

The new fund underscores how investors are still willing to write large checks for teams that can connect software, machine learning and laboratory science. For limited partners, the appeal is not just exposure to biotech, but to the infrastructure layer that can make scientific research faster, more repeatable and more scalable.